Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis
Author:
Affiliation:
1. Department of Rheumatology, North Bristol NHS Trust, Bristol, UK
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/60/5/e156/37935784/keaa698.pdf
Reference5 articles.
1. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis;Betteridge;Ann Rheum Dis,2009
2. Clinical significance of myositis-specific autoantibodies;Nakashima;Immunol Med,2018
3. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review;Jia;Clin Rheumatol,2019
4. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis;Riley;Rheumatology (Oxford),2008
5. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis;Schiffenbauer;Semin Arthritis Rheum,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case report: A case of resistant anti‐SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab;International Journal of Rheumatic Diseases;2024-03
2. Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature;Clinical, Cosmetic and Investigational Dermatology;2022-09
3. Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma;Journal of the American Academy of Dermatology;2022-07
4. Multiple drugs;Reactions Weekly;2021-08
5. The effects of infliximab in treating idiopathic inflammatory myopathies: A review article;Dermatologic Therapy;2021-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3